Drug data last refreshed 16h ago · AI intelligence enriched 4w ago
PILOPINE HS is a small-molecule ophthalmic gel approved in 1984 for glaucoma and ocular hypertension management. The product delivers sustained therapeutic effect through a gel formulation applied directly to the eye. It represents a mature, established therapy in the ophthalmology space.
As LOE approaches, commercial teams are typically in maintenance-or-harvest mode with smaller field presence and focused retention strategies rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
PILOPINE HS offers limited career momentum given its LOE-approaching lifecycle stage and minimal linked job openings (0 identified). Roles on this product are typically support or transition-focused rather than high-growth opportunities.
Worked on PILOPINE HS at Alcon? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.